UNITED THERAPEUTICS Corp (UTHR) insider trading

By person

14 insiders · 309 transactions

145×

Martine Rothblatt holds 145 times base salary in stock. $225.43M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $602.72, the price Common Stock was last bought or sold at on the open market here, on 5 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Martine A Rothblatt

Chairperson & CEO

—

$118.41M (294) scheduled

−$118.41M

374,024

0.8720%

$225.43M

+6.9%

Paul A Mahon

EVP & General Counsel

—

$9.49M (15) scheduled

−$9.49M

45,172

0.1053%

$27.23M

+22.6%

Richard Giltner

Director

—

21,884

0.0510%

$13.19M

+25.6%

Michael Benkowitz

President and COO

—

19,046

0.0444%

$11.48M

−83.8%

James Edgemond

CFO and Treasurer

—

18,876

0.0440%

$11.38M

+130.6%

Ray Kurzweil

Director

—

13,320

0.0311%

$8.03M

+10.3%

Tommy G Thompson

Director

—

8,480

0.0198%

$5.11M

0.0%

Nilda Mesa

Director

—

5,580

0.0130%

$3.36M

−7.1%

Judy D. Olian

Director

—

5,555

0.0130%

$3.35M

−25.0%

Christopher Causey

Director

—

4,190

0.0098%

$2.53M

+21.4%

Louis W Sullivan

Director

—

2,983

0.0070%

$1.80M

−79.8%

Christopher Patusky

Director

—

2,140

0.0050%

$1.29M

+137.8%

Raymond Dwek

Director

—

1,750

0.0041%

$1.05M

0.0%

Jan Malcolm

Director

—

450

0.0010%

$271.22K

—

UNITED THERAPEUTICS Corp

What the insiders did Scheduled selling only

By person